These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 8728173)

  • 21. Failure of icodextrin to provide adequate ultrafiltration in continuous ambulatory peritoneal dialysis patients.
    Thodis E; Passadakis P; Panagoutsos S; Marinopoulos D; Vargemezis V
    Adv Perit Dial; 1999; 15():171-4. PubMed ID: 10682096
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predictors of a favourable response to icodextrin in peritoneal dialysis patients with ultrafiltration failure.
    Wiggins KJ; Rumpsfeld M; Blizzard S; Johnson DW
    Nephrology (Carlton); 2005 Feb; 10(1):33-6. PubMed ID: 15705179
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Icodextrin provides long dwell peritoneal dialysis and maintenance of intraperitoneal volume.
    Peers E; Gokal R
    Artif Organs; 1998 Jan; 22(1):8-12. PubMed ID: 9456219
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Peritoneal transport with icodextrin solution.
    Heimbürger O
    Contrib Nephrol; 2006; 150():97-103. PubMed ID: 16720998
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Future clinical research with icodextrin-containing solutions.
    Shockley TR; Wang T; Lindholm B
    Perit Dial Int; 1997; 17 Suppl 2():S70-4. PubMed ID: 9163802
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Single daily overnight (12-h dwell) use of 7.5% glucose polymer (Mw 18700; Mn 7300) +0.35% glucose solution: a 3-month study.
    Mistry CD; Gokal R
    Nephrol Dial Transplant; 1993; 8(5):443-7. PubMed ID: 7688108
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of intraperitoneal pressure and the effect of different osmotic agents on intraperitoneal pressure in children.
    Rusthoven E; van der Vlugt ME; van Lingen-van Bueren LJ; van Schaijk TC; Willems HL; Monnens LA; Schröder CH
    Perit Dial Int; 2005; 25(4):352-6. PubMed ID: 16022091
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Icodextrine peritoneal dialysis solution in clinical practice].
    Opatrná S
    Vnitr Lek; 2008 Dec; 54(12):1155-60. PubMed ID: 19140524
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New solutions for peritoneal dialysis in adult and pediatric patients.
    Shockley TR; Martis L; Tranaeus AP
    Perit Dial Int; 1999; 19 Suppl 2():S429-34. PubMed ID: 10406559
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanisms of Crystalloid versus Colloid Osmosis across the Peritoneal Membrane.
    Morelle J; Sow A; Fustin CA; Fillée C; Garcia-Lopez E; Lindholm B; Goffin E; Vandemaele F; Rippe B; Öberg CM; Devuyst O
    J Am Soc Nephrol; 2018 Jul; 29(7):1875-1886. PubMed ID: 29844208
    [No Abstract]   [Full Text] [Related]  

  • 31. [Icodextrin in peritoneal dialysis therapy].
    Grzegorzewska AE; Antczak-Jedrzejczak D
    Przegl Lek; 1999; 56(12):812-6. PubMed ID: 10789195
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The variability in ultrafiltration achieved with icodextrin, possibly explained.
    Venturoli D; Jeloka TK; Ersoy FF; Rippe B; Oreopoulos DG
    Perit Dial Int; 2009; 29(4):415-21. PubMed ID: 19602607
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mitigating peritoneal membrane characteristics in modern peritoneal dialysis therapy.
    Davies SJ
    Kidney Int Suppl; 2006 Nov; (103):S76-83. PubMed ID: 17080116
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ultrafiltration characteristics of glucose polymers with low polydispersity.
    Leypoldt JK; Hoff CM; Piscopo D; Carr SN; Svatek JM; Holmes CJ
    Perit Dial Int; 2013; 33(2):124-31. PubMed ID: 23123667
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Determination of individual ultrafiltration time (APEX) and purification phosphate time by peritoneal equilibration test: application to individual peritoneal dialysis modality prescription in children.
    Fischbach M; Lahlou A; Eyer D; Desprez P; Geisert J
    Perit Dial Int; 1996; 16 Suppl 1():S557-60. PubMed ID: 8728270
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metabolic consequences of peritoneal dialysis.
    Burkart J
    Semin Dial; 2004; 17(6):498-504. PubMed ID: 15660581
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Use of icodextrin for diurnal exchange in patients undergoing automatic peritoneal dialysis. Comparison with glucose solutions].
    Bajo MA; Selgas R; del Peso G; Castro MJ; Hevia C; Gil F; Costero O; Olea T; Jiménez C
    Nefrologia; 2002; 22(4):348-55. PubMed ID: 12369126
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Peritoneal fluid transport in CAPD patients with different transport rates of small solutes.
    Sobiecka D; Waniewski J; Weryński A; Lindholm B
    Perit Dial Int; 2004; 24(3):240-51. PubMed ID: 15185772
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sodium removal and peritoneal dialysis modalities: no differences with optimal prescription of icodextrin.
    Fourtounas C; Dousdampanis P; Hardalias A; Vlachojannis JG
    Artif Organs; 2013 Jul; 37(7):E107-13. PubMed ID: 23461737
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The impact of relapsing sterile icodextrin-associated peritonitis on peritoneal dialysis outcome.
    Basile C; De Padova F; Montanaro A; Giordano R
    J Nephrol; 2003; 16(3):384-6. PubMed ID: 12832738
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.